Sox9 directs divergent epigenomic states in brain tumor subtypes

Debosmita Sardar(Baylor College of Medicine), Benjamin Deneen(Baylor College of Medicine), Antrix Jain(Baylor College of Medicine), Kwanha Yu(Baylor College of Medicine), Ali Jalali(Baylor College of Medicine), Srinidhi Varadharajan(Baylor College of Medicine), Stephen C. Mack(Hospital for Sick Children), Brittney Lozzi(Baylor College of Medicine), Rachel Naomi Curry(Baylor College of Medicine), Kavitha Rajendran(Baylor College of Medicine), Amanda Reyes(Baylor College of Medicine), Hsiao‐Chi Chen(Baylor College of Medicine), Alexis Cervantes(Baylor College of Medicine), Carrie Mohila(Baylor College of Medicine)
Proceedings of the National Academy of Sciences
July 15, 2022
10.1073/pnas.2202015119
Cited by 26

Related Papers

Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
|Nature|2014|621
Glioma Stem Cell–Specific Superenhancer Promotes Polyunsaturated Fatty-Acid Synthesis to Support EGFR Signaling
|Cancer Discovery|2019|181
Remote neuronal activity drives glioma progression through SEMA4F
|Nature|2023|172
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
|Cancer Discovery|2021|90